Showing results (1531-1540 of 2,067) with videos related to

Sort By:
Pageof 207
Japanese Journal of Infectious Diseases|December 4, 2008
T serotypes and antimicrobial susceptibilities of group A streptococcus isolates from pediatric pharyngotonsillitisKeiji Funahashi, Kazumasa Nakane, Naoko Yasuda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 25, 2008
Five-day oral cefditoren pivoxil versus 10-day oral amoxicillin for pediatric group A streptococcal pharyngotonsillitisTakao Ozaki, Naoko Nishimura, Michio Suzuki, et al.
Neuroscience Research|March 13, 2003
Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1Hirokazu Ohtaki, Hisayuki Funahashi, Kenji Dohi, et al.
Neurourology and Urodynamics|December 1, 2018
The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociceptionTsuyoshi Majima, Kenichi Mori, Katsumi Kadekawa, et al.
Biosensors|March 26, 2025
Attention Affecting Response Inhibition in Overweight Adults with Food AddictionXiaotong Liu, Guangying Pei, Jiayuan Zhao, et al.
Surgery Today|September 14, 2013
Risk factors for parastomal hernia in Japanese patients with permanent colostomyKimihiko Funahashi, Takayuki Suzuki, Yasuo Nagashima, et al.
Immunology Letters|November 2, 2013
Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetesShinsuke Nakata, Akihisa Imagawa, Yugo Miyata, et al.
International Journal of Rheumatic Diseases|November 7, 2015
Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritisMasayo Kojima, Toshihisa Kojima, Sadao Suzuki, et al.
Scientific Reports|October 7, 2020
Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritisShinya Hayashi, Tsukasa Matsubara, Koji Fukuda, et al.
British Journal of Cancer|February 27, 2014
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) statesT Yoshida, Y Ozawa, T Kimura, et al.
Pageof 207